Resistance of Bacteria to Biocides
Overview
Authors
Affiliations
Biocides and formulated biocides are used worldwide for an increasing number of applications despite tightening regulations in Europe and in the United States. One concern is that such intense usage of biocides could lead to increased bacterial resistance to a product and cross-resistance to unrelated antimicrobials including chemotherapeutic antibiotics. Evidence to justify such a concern comes mostly from the use of health care-relevant bacterial isolates, although the number of studies of the resistance characteristics of veterinary isolates to biocides have increased the past few years. One problem remains the definition of "resistance" and how to measure resistance to a biocide. This has yet to be addressed globally, although the measurement of resistance is becoming more pressing, with regulators both in Europe and in the United States demanding that manufacturers provide evidence that their biocidal products will not impact on bacterial resistance. Alongside evidence of potential antimicrobial cross-resistance following biocide exposure, our understanding of the mechanisms of bacterial resistance and, more recently, our understanding of the effect of biocides to induce a mechanism(s) of resistance in bacteria has improved. This article aims to provide an understanding of the development of antimicrobial resistance in bacteria following a biocide exposure. The sections provide evidence of the occurrence of bacterial resistance and its mechanisms of action and debate how to measure bacterial resistance to biocides. Examples pertinent to the veterinary field are used where appropriate.
Cho Y, Song M, Kim D, Kim M, Lee K Heliyon. 2025; 11(2):e42134.
PMID: 39925360 PMC: 11804698. DOI: 10.1016/j.heliyon.2025.e42134.
Kuznetsova M, Nesterova L, Mihailovskaya V, Selivanova P, Kochergina D, Karipova M Int J Mol Sci. 2025; 26(1.
PMID: 39796210 PMC: 11721292. DOI: 10.3390/ijms26010355.
Highly Effective Biocides against Reveal New Mechanistic Insights Across Gram-Negative Bacteria.
Sanchez C, Vargas-Cuebas G, Michaud M, Allen R, Morrison-Lewis K, Siddiqui S ACS Infect Dis. 2024; 10(11):3868-3879.
PMID: 39440866 PMC: 11555683. DOI: 10.1021/acsinfecdis.4c00433.
Sattar S, Zargar B, Tetro J Infect Prev Pract. 2024; 6(4):100395.
PMID: 39346619 PMC: 11437760. DOI: 10.1016/j.infpip.2024.100395.
Willmott T, Kelly P, Jadaan L, Gifford D, Mercer S, Humphreys G Appl Environ Microbiol. 2024; 90(10):e0066624.
PMID: 39320084 PMC: 11497780. DOI: 10.1128/aem.00666-24.